Non-neuronal cells in amyotrophic lateral sclerosis—from pathogenesis to biomarkers

BF Vahsen, E Gray, AG Thompson, O Ansorge… - Nature Reviews …, 2021 - nature.com
The prevailing motor neuron-centric view of amyotrophic lateral sclerosis (ALS)
pathogenesis could be an important factor in the failure to identify disease-modifying therapy …

The microglial component of amyotrophic lateral sclerosis

BE Clarke, R Patani - Brain, 2020 - academic.oup.com
Microglia are the primary immune cells of the CNS, carrying out key homeostatic roles and
undergoing context-dependent and temporally regulated changes in response to injury and …

The obese brain: mechanisms of systemic and local inflammation, and interventions to reverse the cognitive deficit

V Salas-Venegas, RP Flores-Torres… - Frontiers in Integrative …, 2022 - frontiersin.org
Overweight and obesity are now considered a worldwide pandemic and a growing public
health problem with severe economic and social consequences. Adipose tissue is an organ …

Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD

G Krishnan, D Raitcheva, D Bartlett… - Nature …, 2022 - nature.com
GGGGCC repeat expansion in C9ORF72, which can be translated in both sense and
antisense directions into five dipeptide repeat (DPR) proteins, including poly (GP), poly …

Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo

H Riemenschneider, F Simonetti, U Sheth… - Acta Neuropathologica …, 2023 - Springer
Cytoplasmic aggregation and concomitant nuclear clearance of the RNA-binding protein
TDP-43 are found in~ 90% of cases of amyotrophic lateral sclerosis and~ 45% of patients …

Immunotherapies for neurodegenerative diseases

I Mortada, R Farah, S Nabha, DM Ojcius… - Frontiers in …, 2021 - frontiersin.org
The current treatments for neurodegenerative diseases are mostly symptomatic without
affecting the underlying cause of disease. Emerging evidence supports a potential role for …

Cell‐to‐cell transmission of C9orf72 poly‐(Gly‐Ala) triggers key features of ALS/FTD

B Khosravi, KD LaClair, H Riemenschneider… - The EMBO …, 2020 - embopress.org
The C9orf72 repeat expansion causes amyotrophic lateral sclerosis and frontotemporal
dementia, but the poor correlation between C9orf72‐specific pathology and TDP‐43 …

Glial cells—The strategic targets in amyotrophic lateral sclerosis treatment

T Filipi, Z Hermanova, J Tureckova, O Vanatko… - Journal of clinical …, 2020 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease, which is characterized by
the degeneration of motor neurons in the motor cortex and the spinal cord and subsequently …

Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation

F Liu, D Morderer, MC Wren… - Acta Neuropathologica …, 2022 - Springer
The most common inherited cause of two genetically and clinico-pathologically overlapping
neurodegenerative diseases, amyotrophic lateral sclerosis (ALS) and frontotemporal …

Amyotrophic lateral sclerosis: molecular mechanisms, biomarkers, and therapeutic strategies

X Yang, Y Ji, W Wang, L Zhang, Z Chen, M Yu, Y Shen… - Antioxidants, 2021 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with the progressive
loss of motor neurons, leading to a fatal paralysis. According to whether there is a family …